diazoxide and pasireotide

diazoxide has been researched along with pasireotide in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Bonora, E; Castelli, C; Dauriz, M; Ferdeghini, M; Fuini, A; Landoni, L; Malleo, G; Maneschi, C; Moghetti, P; Tomezzoli, A	1
Albertelli, M; Amarù, J; Cacciatore, C; Cangiano, B; Falconi, M; Gatto, F; Persani, L; Sileo, F; Vitale, G	1

Other Studies

2 other study(ies) available for diazoxide and pasireotide

Article	Year
A Case Report of Insulinoma Relapse on Background Nesidioblastosis: A Rare Cause of Adult Hypoglycemia. The Journal of clinical endocrinology and metabolism, 2019, 03-01, Volume: 104, Issue:3 Topics: Diazoxide; Female; Humans; Hypoglycemia; Insulinoma; Middle Aged; Neoplasm Recurrence, Local; Nesidioblastosis; Pancreas; Pancreatectomy; Pancreatic Neoplasms; Somatostatin; Splenectomy; Treatment Outcome	2019
Off-label pasireotide treatment in one insulinoma patient with an atypical presentation and intolerant to diazoxide. Endocrine, 2020, Volume: 70, Issue:2 Topics: Diazoxide; Humans; Insulinoma; Off-Label Use; Pancreatic Neoplasms; Somatostatin	2020

Article

Year

A Case Report of Insulinoma Relapse on Background Nesidioblastosis: A Rare Cause of Adult Hypoglycemia.

The Journal of clinical endocrinology and metabolism, 2019, 03-01, Volume: 104, Issue:3

Topics: Diazoxide; Female; Humans; Hypoglycemia; Insulinoma; Middle Aged; Neoplasm Recurrence, Local; Nesidioblastosis; Pancreas; Pancreatectomy; Pancreatic Neoplasms; Somatostatin; Splenectomy; Treatment Outcome

2019

Off-label pasireotide treatment in one insulinoma patient with an atypical presentation and intolerant to diazoxide.

Endocrine, 2020, Volume: 70, Issue:2

Topics: Diazoxide; Humans; Insulinoma; Off-Label Use; Pancreatic Neoplasms; Somatostatin

2020